ARTICLE | Clinical News
IP 751: Phase II
December 9, 2002 8:00 AM UTC
In a placebo-controlled Phase II study of 21 patients with chronic pain resulting from spinal or peripheral nerve injuries, IP 751 gave a significant reduction in neuropathic pain, as measured by visu...